+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Sale

Laboratory Proficiency Testing Market - Global Forecast 2025-2032

  • PDF Icon

    Report

  • 198 Pages
  • October 2025
  • Region: Global
  • 360iResearch™
  • ID: 5674432
UP TO OFF until Jan 01st 2026
1h Free Analyst Time
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

Laboratory proficiency testing is transforming from a routine compliance activity into a central pillar of quality assurance for laboratories worldwide. The Laboratory Proficiency Testing Market is shaped by multiple factors—technological advances, shifting regulations, and evolving operational expectations—prompting decision-makers to view proficiency testing as an enabler of reliable and consistent analytical performance.

Market Snapshot: Laboratory Proficiency Testing Market Growth Drivers

The Laboratory Proficiency Testing Market grew from USD 2.39 billion in 2024 to USD 2.59 billion in 2025 and is projected to reach USD 4.46 billion by 2032, reflecting a compound annual growth rate (CAGR) of 8.08%. Market expansion is propelled by stricter accreditation standards, increasing complexity in laboratory methodologies, and a heightened global emphasis on quality and regulatory compliance. Innovations in digital platforms, automation, and data analytics continue to reshape operational models and program delivery, impacting every stage of the laboratory value chain.

Scope & Segmentation: Comprehensive Coverage of Laboratory Proficiency Testing

This report offers a detailed breakdown and strategic analysis of the laboratory proficiency testing landscape:

  • Categories: Biological Analysis, Chemical Analysis, Microbiology Analysis
  • Biological Analysis Methods: Enzyme Analysis, Immunoassay, Molecular Analysis
  • Chemical Analysis Types: Inorganic Chemical, Organic Chemical
  • Microbiology Analysis: Bacteria, Fungi, Viruses
  • Applications: Environmental (Air, Soil, Water), Food and Beverages (Bakery, Beverages, Dairy, Meat and Poultry), Healthcare and Diagnostics (Clinical Chemistry, Hematology, Immunology, Microbiology), Pharmaceutical (Drug Development, GMP Compliance, Quality Control), Tobacco (Nicotine Analysis, Quality Control)
  • End Users: Diagnostic Laboratories (Hospital, Independent, Specialty), Environmental Testing Labs (Private, Public), Food and Beverage Manufacturers (Beverage, Confectionery, Dairy, Meat Processors), Government Agencies (Environmental, Food Safety, Health Departments), Pharmaceutical Companies (Biotech, Generic, Large Pharma)
  • Distribution Channels: Direct Sales (Authorized Representatives, Original Manufacturers), Distributors (Tier One, Tier Two), Online Sales (Company Websites, Third-Party Platforms)
  • Geographies: Americas (North America, Latin America), Europe, Middle East & Africa, Asia-Pacific. Key countries include United States, Canada, Brazil, United Kingdom, Germany, France, China, India, Japan, among others.
  • Technology Drivers: Integration of digital workflows, cloud-based platforms, automation technologies, artificial intelligence, machine learning, centralized and remote testing models

Key Takeaways for Senior Decision-Makers

  • Adoption of proficiency testing is increasingly strategic, helping laboratories demonstrate ongoing reliability, not just periodic compliance.
  • Technological advancements, including AI and cloud platforms, are enhancing data analysis, reporting speed, and anomaly detection capabilities.
  • Regulatory harmonization across regions is streamlining cross-border proficiency testing, reducing administrative overhead for global laboratories.
  • Expanding remote and distance testing models are enabling greater participation, especially for smaller and underserved laboratories.
  • Leading providers differentiate through consultative services, integrated platforms, and collaborative alliances with reagent, instrumentation, and accreditation partners.
  • Distribution models are shifting toward hybrid and online channels, widening program access and improving user experience.

Tariff Impact: Navigating Emerging Cost and Supply Chain Challenges

Upcoming tariff adjustments in the United States are adding complexity to sourcing and supply chain planning for proficiency testing providers. Increased import duties on reagents and instrumentation are prompting providers to reassess supplier relationships, optimize logistics, and pursue regional procurement strategies. Laboratories are responding by prioritizing critical analytes and refining their participation schedules, ensuring continued compliance amid rising costs and longer lead times. Effective stakeholder communication and program agility are key to addressing these market headwinds.

Methodology & Data Sources

This report uses a multi-faceted approach combining primary interviews with laboratory directors, quality managers, and regulatory authorities, and secondary research including technical publications and industry reports. Analytical frameworks integrate qualitative insights, segmentation analysis, and validation measures such as peer review and expert panel feedback, ensuring data accuracy and relevance.

Why This Report Matters: Strategic Benefits for Industry Leaders

  • Enables benchmarking of current practices and technology adoption against regional and global standards.
  • Supports strategic planning for compliance, supply chain risk, and service portfolio expansion through actionable segmentation insights.
  • Provides evidence-based guidance to drive investment in digital transformation, partnership development, and competitive differentiation.

Conclusion: Evolving Landscape, Strategic Opportunities

Laboratory proficiency testing is evolving into a strategic component of laboratory quality management, driven by digital transformation and global regulatory trends. Organizations that align with these developments will strengthen performance, enhance resilience, and secure long-term leadership in the sector.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
3. Executive Summary
4. Market Overview
5. Market Insights
5.1. Integration of artificial intelligence in validation workflows to predict device failures before production
5.2. Adoption of automated test platforms for remote validation under evolving regulatory guidelines
5.3. Implementation of blockchain technology for secure traceability in device testing and audits
5.4. Development of digital twin models for real time simulation and performance verification
5.5. Increased emphasis on software security and cybersecurity validation following FDA guidance
5.6. Expansion of real world evidence analytics to support post market surveillance and risk assessments
5.7. Implementation of IoT connectivity for continuous compliance monitoring and data collection
5.8. Use of augmented reality tools for virtual inspection and operator usability validation processes
5.9. Adoption of risk based verification frameworks for combination products integrating drug device functionalities
6. Cumulative Impact of United States Tariffs 2025
7. Cumulative Impact of Artificial Intelligence 2025
8. Medical Device Validation & Verification Market, by Services
8.1. Validation Services
8.1.1. Design Validation
8.1.2. Process Validation
8.1.3. Software Validation
8.2. Verification Services
8.2.1. Labeling & Packaging
8.2.2. Material Verification
8.2.3. Performance Testing
9. Medical Device Validation & Verification Market, by Device Class
9.1. Class I
9.2. Class II
9.3. Class III
10. Medical Device Validation & Verification Market, by Device Type
10.1. Imaging Systems
10.1.1. CT Scanners
10.1.2. MRI Systems
10.1.3. Ultrasound Systems
10.1.3.1. 2D Ultrasound
10.1.3.2. 3D/4D Ultrasound
10.1.4. X-Ray Systems
10.2. In Vitro Diagnostics
10.2.1. Blood Glucose Monitors
10.2.2. Immunoassay Analyzers
10.2.3. Molecular Diagnostics
10.3. Monitoring Devices
10.3.1. Blood Pressure Monitors
10.3.2. ECG Monitors
10.3.3. Fetal Monitors
10.3.4. Pulse Oximeters
10.4. Surgical Instruments
10.4.1. General Surgery Instruments
10.4.2. Laparoscopic Instruments
10.4.3. Orthopedic Instruments
10.5. Therapeutic Devices
10.5.1. Defibrillators
10.5.2. Dialysis Machines
10.5.3. Infusion Pumps
10.5.4. Ventilators
11. Medical Device Validation & Verification Market, by Application
11.1. Cardiology
11.2. Neurology
11.3. Oncology
11.4. Orthopedics
11.5. Respiratory
12. Medical Device Validation & Verification Market, by End User
12.1. Ambulatory Surgical Centers
12.2. Contract Research Organizations
12.3. Diagnostic Laboratories
12.4. Hospitals
13. Medical Device Validation & Verification Market, by Region
13.1. Americas
13.1.1. North America
13.1.2. Latin America
13.2. Europe, Middle East & Africa
13.2.1. Europe
13.2.2. Middle East
13.2.3. Africa
13.3. Asia-Pacific
14. Medical Device Validation & Verification Market, by Group
14.1. ASEAN
14.2. GCC
14.3. European Union
14.4. BRICS
14.5. G7
14.6. NATO
15. Medical Device Validation & Verification Market, by Country
15.1. United States
15.2. Canada
15.3. Mexico
15.4. Brazil
15.5. United Kingdom
15.6. Germany
15.7. France
15.8. Russia
15.9. Italy
15.10. Spain
15.11. China
15.12. India
15.13. Japan
15.14. Australia
15.15. South Korea
16. Competitive Landscape
16.1. Market Share Analysis, 2024
16.2. FPNV Positioning Matrix, 2024
16.3. Competitive Analysis
16.3.1. SGS SA
16.3.2. Bureau Veritas SA
16.3.3. ALS Limited
16.3.4. Applus Services SA
16.3.5. ATIC (Guangzhou) Co., Ltd.
16.3.6. Charles River Laboratories International, Inc.
16.3.7. CSA Group Testing & Certification Inc.
16.3.8. Dekra SE
16.3.9. DNV AS
16.3.10. Element Materials Technology Group Limited
16.3.11. Eurofins Scientific SE
16.3.12. IFS Aktiebolag
16.3.13. Intertek Group PLC
16.3.14. Kiwa NV
16.3.15. LabWare, Inc.
16.3.16. Medistri SA
16.3.17. NSF International
16.3.18. QuEST Global Services Pte. Ltd.
16.3.19. Riverside Company
16.3.20. Steris Laboratories
16.3.21. TUV Nord AG
16.3.22. TUV Rheinland Group
16.3.23. TÜV SÜD
16.3.24. UL LLC

Companies Mentioned

The companies profiled in this Laboratory Proficiency Testing market report include:
  • SGS SA
  • Bureau Veritas S.A.
  • Intertek Group plc
  • Eurofins Scientific SE
  • LGC Limited
  • Thermo Fisher Scientific Inc.
  • Bio-Rad Laboratories, Inc.
  • R-Biopharm AG
  • Neogen Corporation
  • Randox Laboratories Ltd

Table Information